The Hospital Sant Joan de Déu Barcelona and Oxolife have received the CATALONIA.HEALTH 2025 Award (formerly Bioèxit) during the 11th edition of the Nit, the annual event of reference in the field of health and life sciences in Catalonia, organised by CATALONIA.HEALTH and life sciences in Catalonia, organised by CATALONIA.HEALTH. The award recognises relevant trajectories and projects based on the axes of innovation, science and business, and which stand out for their excellence in areas such as scientific innovation, industrialization innovation, industrialisation, regulatory milestones and international expansion.
The Hospital Sant Joan de Déu Barcelona has been distinguished ...
La startup SocialDiabetes, membre de CATALONIA.HEALTH, anuncia una aliança estratègica amb l’empresa Listen.Doctor i la multinacional tecnològica Babel per introduir solucions avançades en intel·ligència artificial i tecnologies de monitoratge que estan transformant l’atenció sanitària
The technology centre Eurecat, a member of CATALONIA.HEALTH, will apply the new single-cell genomic technology to evaluate the health impact of a diet based on alternative protein sources and characterize cells from cultivated meat, thus moving towards precision nutrition
The venture capital company Inveready has acquired Enantia, a company specialized in contract research (CRO). Both companies are members of CATALONIA.HEALTH. The acquisition has been done through INVACO, one of the companies controlled by the venture capital fund Inveready Biotech IV.
The pharmaceutical company Bionure and the Hospital del Mar Research Institute, both members of CATALONIA.HEALTH, establish a strategic collaboration to transform the treatment landscape of neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS) or Epilepsy, with RNA therapies.
After several years participating laterally at the Mobile World Congress (MWC), the largest and most influential event on connectivity worldwide, and at 4YFN, the parallel event to the MWC of reference for the international entrepreneurial ecosystem, CATALONIA.HEALTH lands at the 2025 edition with a stand that will allow to present, in an interactive way, medical technologies from 8 companies' members.
The venture capital company Asabys Partners, a member of CATALONIA.HEALTH, co-leads a $50 million funding round for the biotechnology company Quibim.
The venture capital company Ship2B Ventures, a member of CATALONIA.HEALTH, created a financing round with the European consortium formed with LUMO Labs through its BSocial Impact Fund to obtain funding for the technology startup Sycai Medical.
The biotech company Aptadel Therapeutics, a member of CATALONIA.HEALTH, has announced a partnership with the Little Warrior Foundation. The foundation, based in the United States, will provide $500,000 in funding for its therapeutic programme against Ewing's sarcoma, specifically for the pre-clinical phases.
The biopharmaceutical company HIPRA, a member of CATALONIA.HEALTH, launches HIPRA Biotech Services, its new unit aimed at offering development and manufacturing services of biological products to companies in the biotechnology and pharmaceutical sectors. HIPRA Biotech Services covers the entire life cycle of the product, from the initial phases of research and development to production on a commercial scale.
Triana, a company specialised in packaging and manufacturing of plastic containers for the pharmaceutical industry and a member of CATALONIA.HEALTH, announces its participation in two key events in the packaging sector, Pharmapack and Paris Packaging Week 2025, which will take place in the city of Paris during the month of January.
The pharmaceutical company Almirall, a member of CATALONIA.HEALTH, announced at the JPMorgan HealthCare 2025 Conference, an update of its strategy and business perspectives.
Medical technology company Vitalera, a member of CATALONIA.HEALTH, achieved a significant milestone by successfully completing the rigorous re-classification process to MDR Class IIa certification.
The venture capital company Invivo Partners, a member of CATALONIA.HEALTH, announced the closing of a €20 million Series A financing round for the biotechnology company Neumirna Therapeutics.
The call for the eleventh edition of the CATALONIA.HEALTH Award is now open. Previously known as Bioèxit Award, the recognition joins the change of the association's brand and adapts the name to include all sector actors.
Sign up for the 2017 Health & Bio Team Dating, 21 November!
Konstantinidou, founder and CEO of DNANutricoach, is one of the success stories to come out of this event that brings together scientists from the health and life sciences arena and business people
Health & Bio Team Dating was launched in 2015 based on the fact that Catalonia has a rich ecosystem of great scientists, entrepreneurs, investors and institution but lacks collaborations among these groups. So, on one hand there are many scientific projects that could be taken to market by new start-ups if only they had someone to take care of setting up a business plan and raising funds. On the other hand, there are many experts in business administration and management that want to set out on their own and find new projects in the healthcare and life sciences sector but don't know where to look for them.
These events, which are moving into their second edition this year, were created out of the need to pair scientific research of excellence with expertise in business development. The first edition, held in 2015, brought together 60 projects and executives to hold more than 200 meetings. Of these, 6 teams have reached some sort of agreement or collaboration. One of these teams is the one made up of Valentini Konstantinidou and Chenghan Yang who, as a result of their meeting at Health & Bio Team Dating, signed an agreement through which IESE MBA students can collaborate with Konstantinidou’s start-up: DNANutricoach. We spoke to them about their experience at the first edition of Health & Bio Team Dating.
What did you get out of participating in this speed dating event?
Valentini Konstantinidou: It was the first event of this type I'd ever attended and I went with the idea of looking for synergies (ideas, knowledge of the sector, etc.) but I found tons of interesting contacts that opened my eyes to new perspectives. Thanks to the event, I signed a collaboration agreement with IESE to have their MBA students do summer internships in my company, giving me a more business-oriented view that has helped me learn a lot and grow the company.
Chenghan Yang: I met with many different start-ups and closed collaboration agreements with two of them to allow students to do internships there.
What stage is your business project at now?
V. K: We are in the development phase, but we are starting to find our first clients and, as we don't yet have any external funding, we’re growing organically: the first sales will allow us to make our first investments.
Creating a science/business tandem has been key to:
V. K: Provide all of the knowledge that, as a scientist, I don't have. An MBA student contributes knowledge on finance, marketing, business development, etc. and it's not just theory, we are putting it in practice to grow the company. When the company is more consolidated, I will be able to have this type of employee on staff.
What advice would you give those participating in the second edition?
V. K: To leave any shame at home and take advantage to speak with as many people as possible, because it is a great incubator of contacts that yields unexpected results.
C.Y: The IESE MBA students have four or five years of professional experience before starting the program, some in the healthcare sector, so they can be a good source of ideas and help to develop projects jointly with start-ups.
Cookies settings
We collect and process your personal information for the following purposes: Analytics, Security & Marketing.
Comments